New diabetes clinical trial: A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil
Published on: 2026-04-08T04:00:00Z Conditions : Diabete Type 2 Interventions : Drug: Efsubaglutide Alfa Injection; Drug: Placebo Sponsors : Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. Not yet recruiting https://ift.tt/nHjNLx3